The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

CARPALL: Immunotherapy With CD19/22 CAR T-cells for CD19+ Haematological Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02443831
Recruitment Status : Active, not recruiting
First Posted : May 14, 2015
Last Update Posted : May 30, 2024
Information provided by (Responsible Party):
University College, London